Evelyn Zellmeier

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients.

Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 11, 2017

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Journal: Leukemia

Published: August 02, 2017

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Journal: Leukemia

Published: August 02, 2017

Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.

Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.

Journal: Genes, chromosomes & cancer

Published: June 08, 2016

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Journal: Blood

Published: January 25, 2016

The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor.

The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor.

Journal: Scientific reports

Published: January 12, 2016

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.

Journal: Nature communications

Published: October 20, 2015

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.

Journal: Haematologica

Published: September 08, 2015

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.

Journal: Blood

Published: June 14, 2014

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.

Journal: Haematologica

Published: May 13, 2014

The NPM1 mutation type has no impact on survival in cytogenetically normal AML.

The NPM1 mutation type has no impact on survival in cytogenetically normal AML.

Journal: PloS one

Published: April 26, 2014

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 09, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026